ArticleProceedings of the National Academy of Sciences of the United States of America2016

Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.

Istvan Horvath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.